---
title: "BIOX: Stable 4Q26 revenues and improved cost controls offset ongoing net losses and portfolio transitions"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298970405.md"
description: "Revenues remained stable in 4Q26, with strong Crop Nutrition growth offsetting declines elsewhere, while FY26 revenues fell 18% year-over-year. Cost actions improved SG&A and Adjusted EBITDA, but net losses persisted. Focus remains on liability management, gross profit expansion, and operational efficiency.Original document: Bioceres Crop Solutions Corp. [BIOX] Slides Release — Sep. 15 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-14T23:22:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298970405.md)
  - [en](https://longbridge.com/en/news/298970405.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298970405.md)
generator: "portal-rs"
---

# BIOX: Stable 4Q26 revenues and improved cost controls offset ongoing net losses and portfolio transitions

Revenues remained stable in 4Q26, with strong Crop Nutrition growth offsetting declines elsewhere, while FY26 revenues fell 18% year-over-year. Cost actions improved SG&A and Adjusted EBITDA, but net losses persisted. Focus remains on liability management, gross profit expansion, and operational efficiency.

Original document: Bioceres Crop Solutions Corp. \[BIOX\] Slides Release — Sep. 15 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BIOX.US](https://longbridge.com/en/quote/BIOX.US.md)

## Related News & Research

- [BIOX Q4'26 Earnings: EPS estimate is (0.06) USD](https://longbridge.com/en/news/297774037.md)
- [BIOX Q4'26 Earnings: EPS estimate is (0.06) USD](https://longbridge.com/en/news/298721362.md)
- [What the West misses when it judges Chinaâs dogged AI pursuit](https://longbridge.com/en/news/300214004.md)
- [BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI](https://longbridge.com/en/news/300219437.md)
- [China’s consumer stocks face lost decade](https://longbridge.com/en/news/300225845.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**